oncolytic virus

Graphic showing arrows missing the bullseye on a target

Biotech

Transgene's viral cancer vaccine flunks midphase test

The biotech is analyzing aspects of the data including a “positive efficacy trend” in a prespecified subgroup before deciding on its next steps.

Nick Paul Taylor Oct 14, 2024 4:59am

one white and yellow capsule farther ahead than four other same-colored blue capsules

CG sets new bar in bladder cancer, months after huge IPO

May 3, 2024 11:23am

icy water dive polar plunge cold thaw arctic ice freezing

CG Oncology plans IPO ahead of phase 3 bladder cancer readout

Jan 3, 2024 8:25am

Memorial candle in church

Candel’s flame dims as layoffs hit 50% of the team

Nov 28, 2023 11:23am

illustration of businessman man hand giving money to new business idea

CG raises $105M crossover round to fund phase 3 cancer trial

Aug 2, 2023 9:07am

AstraZeneca scraps Transgene pact in blow to oncolytic viruses

May 5, 2023 7:15am